NL-OMON37374已完成不适用
Pharmacokinetic modeling of mitotane - Pharmacokinetic modeling of mitotane
Maxima Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Treatment with oral mitotane ongoing for > 24 weeks;
- •- Age > 18 years;
- •- Able to comply with the protocol;
- •- Written informed consent;
排除标准
- •- Any severe acute or chronic medical or psychiatric condition, or laboratory abnormality that would impart, in the judgment of the investigator, excess risk associated with study participation, or which, in the judgment of the investigator, would make the patient inappropriate for entry into this study.
研究者
相似试验
已完成
不适用
Pharmacogenetics of Mitotaneadrenal canceradrenal neoplasm10001353NL-OMON42303Maxima Medisch Centrum50
已完成
不适用
Pharmacokinetic and Metabolic Analysis of MaotoHealthy adultJPRN-UMIN000023609Kochi Medical School4
已完成
不适用
Pharmacokinetic and pharmacodynamic modelling of routinely used off label drugs in premature neonates10039911Pijn en sedatiePrematurity10028971NL-OMON44214Erasmus MC, Universitair Medisch Centrum Rotterdam600
进行中（未招募）
不适用
Generation of a model for the adaption of the postoperative pain therapy with the strong analgesic, hydromorphone, after planned open heart surgery, during which the strong analgesic, sufentanil, was usedPain therapy after elective cardiac surgeryMedDRA version: 14.0Level: LLTClassification code 10036236Term: Postoperative pain reliefSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-003648-31-DEniversitätsklinikum Erlangen
已完成
1 期
Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome InjectionNeoplasmsNCT02043756CSPC ZhongQi Pharmaceutical Technology Co., Ltd.20